Mark D. Andrews

953 citations

25 papers · 664 indexed · h-index 14

Impact in

Sensory Systems top 5%
- Ion Channels and Receptors
Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis
- Synthesis and Catalytic Reactions
- Synthetic Organic Chemistry Methods
- Catalytic C–H Functionalization Methods

Papers in

Organic Chemistry 16
- Synthetic Organic Chemistry Methods 5
- Asymmetric Synthesis and Catalysis 5
- Synthesis and Catalytic Reactions 3
- Chemical synthesis and alkaloids 3
- Synthesis and pharmacology of benzodiazepine derivatives 2
Pharmacology 4

Co-authors: Mark G. Moloney Andrew G. Brewster David M. Hodgson John C. Vederas Paul A. Glossop Yaoquan Liu Kevin Beaumont Keith Prout
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of the Chemical Society Perkin Transactions 1 (4 papers)The Journal of Organic Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)
Partner nations: United Kingdom United States Canada

In The Last Decade

Mark D. Andrews

25 papers receiving 644 citations

Peers

Countries citing papers authored by Mark D. Andrews

Since Specialization

Citations

This map shows the geographic impact of Mark D. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Andrews more than expected).

Fields of papers citing papers by Mark D. Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Andrews. The network helps show where Mark D. Andrews may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark D. Andrews, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark D. Andrews Line = papers co-authored together Mark D. Andrews links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain Journal of Medicinal Chemistry ·S. Skerratt, Mark D. Andrews, Sharan K. Bagal, James Bilsland, David Brown, Peter J. Bungay, Susan Cole, Karl R. Gibson, Russell M. Jones, Iñaki Morao, Angus Nedderman, Kiyoyuki Omoto, Toshihiko Hosoi, Thomas Ryckmans, Rhonda Joch, Paul A. Stupple, Gareth Waldron	2016	58
2	Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain ACS Medicinal Chemistry Letters ·Mark D. Andrews, J. Bernaud, Kevin Beaumont, Sébastien R. G. Galan, Paul A. Glossop, 高浪洋一, Alan S. Jessiman, Chulwook Kim, W R Hooper, Graham N. Maw, Robert M. Owen, David C. Pryde, Jia Yu, Yong Pu	2015	68
3	Inhibition of TRPM8 Channels Reduces Pain in the Cold Pressor Test in Humans Journal of Pharmacology and Experimental Therapeutics ·Wendy J. Winchester, Vikram Bhat, Sophie Glatt, Susumu Aoto, Z W Liu, Kelly Conlon, Michael Postlethwaite, Pierre‐Philippe Saintot, Dwi Suryaningtyas, J Gosset, P Vasala, Mark D. Andrews, Paul A. Glossop, Michael Palmer, Deng Liu, Susie M. Collins, Kevin Beaumont, David S. Reynolds	2014	72
4	Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: Part 2 Bioorganic & Medicinal Chemistry Letters ·Mark D. Andrews, Alan D. Brown, Lizelle Bouwer, Hidekatsu Kuroda, David W. Gordon, Cesar Ulises Luna Tovar, Zhao Jia-bo	2009	3
5	Design and synthesis of pyridazinone-based 5-HT2C agonists Bioorganic & Medicinal Chemistry Letters ·Charlotte Allerton, Mark D. Andrews, Julian Blagg, David Ellis, JOHN R. KRUEGER, Jasson Alejandro, Kevin K.‐C. Liu, Gordon McMurray, Michael J. Ralph, K A Somanna, Robyn L. Ward, Tarso do Amaral de Souza Cruz	2009	27
6	4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: Design, synthesis and structure–activity relationships Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Mark D. Andrews, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	2009	13
7	Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility Part 1 Bioorganic & Medicinal Chemistry Letters ·Mark D. Andrews, Alan D. Brown, Lizelle Bouwer, Hidekatsu Kuroda, David W. Gordon, Cesar Ulises Luna Tovar, Zhao Jia-bo	2009	6
8	Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT2C agonists Bioorganic & Medicinal Chemistry Letters ·Mark D. Andrews, Jasson Alejandro, Charlotte Allerton, 小林義行, Julian Blagg, Alan D. Brown, David W. Gordon, Gordon McMurray, 赵国党, Liliana Schenon, Tarso do Amaral de Souza Cruz	2009	5
9	Designing rapid onset selective serotonin re-uptake inhibitors. 2: Structure–activity relationships of substituted (aryl)benzylamines Bioorganic & Medicinal Chemistry Letters ·Donald S. Middleton, Mark D. Andrews, Paul A. Glossop, Geoffrey E. Gymer, David Hepworth, Alan S. Jessiman, Patrick S. Johnson, Zhao Jia-bo, Michael J. Pitcher, 祥一伊藤, Alan Stobie, Kim Tang, Paul Morgan	2008	8
10	Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: Structure–activity relationships of (thioalkyl)phenoxy benzylamines Bioorganic & Medicinal Chemistry Letters ·Donald S. Middleton, Mark D. Andrews, Paul A. Glossop, Geoffrey E. Gymer, David Hepworth, Alan S. Jessiman, Patrick S. Johnson, Zhao Jia-bo, Alan Stobie, Kim Tang, А.В. Панин, Barry Jones	2008	8
11	Common tinea infections in children. PubMed ·Mark D. Andrews, S. F. Panyko	2008	70
12	Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure–activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine Bioorganic & Medicinal Chemistry Letters ·Donald S. Middleton, Mark D. Andrews, Paul A. Glossop, Geoffrey E. Gymer, Alan S. Jessiman, Patrick S. Johnson, Zhao Jia-bo, Michael J. Pitcher, 祥一伊藤, Alan Stobie, Kim Tang, Paul Morgan	2005	10
13	Stereocontrolled Syntheses of Kainoid Amino Acids from 7-Azabicyclo[2.2.1]heptadienes Using Tandem Radical Addition-Homoallylic Radical Rearrangement The Journal of Organic Chemistry ·David M. Hodgson, 莫山榊, Mark D. Andrews	2005	20
14	Synthesis of α-Kainic Acid from a 7-Azabicyclo[2.2.1]heptadiene by Tandem Radical Addition−Homoallylic Radical Rearrangement Organic Letters ·David M. Hodgson, 莫山榊, Mark D. Andrews	2005	28
15	Diastereocontrolled synthesis of hydroxylated lactams Journal of the Chemical Society Perkin Transactions 1 ·Mark D. Andrews, Andrew G. Brewster, Mark G. Moloney	2001	1
16	Aldehydes and ketones as dipolarophiles: application to the synthesis of oxapenams Chemical Communications ·Mark D. Andrews, Giles A. Brown, J.P.H. Charmant, Torren M. Peakman, J Clostermann, Geir Olav Kristensen, Timothy Gallagher, Neil J. Hales	1999	9
17	Regioselective Dieckmann cyclisations leading to enantiopure highly functionalised tetramic acid derivatives Journal of the Chemical Society Perkin Transactions 1 ·Mark D. Andrews, Andrew G. Brewster, 樋口光子, Д. М. Заячук, Manahel Khuram, Mark G. Moloney, Keith Prout, D.J. Watkin	1998	54
18	Modification of the Swern Oxidation: Use of a Soluble Polymer-Bound, Recyclable, and Odorless Sulfoxide The Journal of Organic Chemistry ·H. Viemann, Yaoquan Liu, Manuela Cooperman, Mark D. Andrews, John C. Vederas	1998	46
19	A Short Synthesis of an Enantiopure Benzo[e]isoindolinone Synthesis ·Mark D. Andrews, Andrew G. Brewster, Dongsheng Guo, Д. М. Заячук, Mark G. Moloney, Keith Prout, D.J. Watkin	1997	8
20	A concise approach to functionalised, homochiral tetramic acids Tetrahedron Asymmetry ·Mark D. Andrews, Andrew G. Brewster, Mark G. Moloney	1994	15

About Mark D. Andrews

Mark D. Andrews is a scholar working on Organic Chemistry, Pharmacology, Sensory Systems, Complementary and alternative medicine and Cellular and Molecular Neuroscience, having authored 25 papers that have together received 664 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (5 papers), Synthetic Organic Chemistry Methods (5 papers), Asymmetric Synthesis and Catalysis (5 papers), Receptor Mechanisms and Signaling (5 papers), Synthesis and Catalytic Reactions (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Chemical synthesis and alkaloids (3 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). The work is most often cited by research in Sensory Systems (122 citations), Organic Chemistry (290 citations), Dermatology (60 citations), Toxicology (21 citations) and Biochemistry (21 citations). Mark D. Andrews has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Mark G. Moloney, Andrew G. Brewster, David M. Hodgson, John C. Vederas, Paul A. Glossop, Yaoquan Liu, Kevin Beaumont, Keith Prout, D.J. Watkin and Alan S. Jessiman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the Chemical Society Perkin Transactions 1, The Journal of Organic Chemistry, Journal of Pharmacology and Experimental Therapeutics and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact